Author:
Chisholm Kara A.,Gilchrist James M.,Donahue John E.
Reference38 articles.
1. Gilchrist JM. Neurophysiology of neuromuscular transmission and its disorders. In: Blum AS, Rutkove SB, editors. The clinical neurophysiology primer. New Jersey: Humana; 2007. p. 353–68.
2. Grob D, Arsura EL, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann NY Acad Sci. 1987;505:472.
3. Grob D. Natural history of myasthenia gravis. In: Engel AG, editor. Myasthenia gravis and myasthenic disorders. New York: Oxford University Press; 1999. p. 131–45.
4. Holhlfeld R, Wekerle H. The immunopathogenesis of myasthenia gravis. In: Engel AG, editor. Myasthenia gravis and myasthenic disorders. New York: Oxford University Press; 1999. p. 87–110.
5. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain. 2003;126:2304–11.